FindTrial
Sign In

Clinical characteristics in advanced non-small cell lung cancer patients with driver gene mutation: a multicenter, observational clinical study

Clinical characteristics in advanced non-small cell lung cancer patients with driver gene mutation: a multicenter, observational clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057382
Enrollment
Unknown
Registered
2022-03-10
Start date
2022-03-14
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Test group:None

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years of age; 2. According to TNM stage, patients with advanced STAGE IIIB to IV NSCLC with driver gene mutations include EGFR mutation, ALK fusion, ROS1 fusion, RET rearrangement, BRAF V600E mutation, MET abnormality, etc. 3. Normal reading and writing ability, with sound cognitive and behavioral ability; 4. Subjects voluntarily participate in this study and sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with confirmed pathological diagnosis of small cell lung cancer or mixed small cell lung cancer; 2. Patients who cannot cooperate, have cognitive impairment, and have no complete behavioral ability;

Design outcomes

Primary

MeasureTime frame
Progression-free survival and overall survival;—

Countries

China

Contacts

Public ContactJiang Liyan

Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

jiang_liyan2000@126.com+86 13916146759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026